Details for New Drug Application (NDA): 040246
✉ Email this page to a colleague
NDA 040246 describes COMPRO, which is a drug marketed by Padagis Us and is included in one NDA. It is available from two suppliers. Additional details are available on the COMPRO profile page.
The generic ingredient in COMPRO is prochlorperazine. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the prochlorperazine profile page.
The generic ingredient in COMPRO is prochlorperazine. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the prochlorperazine profile page.
Summary for 040246
| Tradename: | COMPRO |
| Applicant: | Padagis Us |
| Ingredient: | prochlorperazine |
| Patents: | 0 |
Suppliers and Packaging for NDA: 040246
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| COMPRO | prochlorperazine | SUPPOSITORY;RECTAL | 040246 | ANDA | Padagis US LLC | 0574-7226 | 0574-7226-12 | 12 PACKET in 1 CARTON (0574-7226-12) / 1 SUPPOSITORY in 1 PACKET |
| COMPRO | prochlorperazine | SUPPOSITORY;RECTAL | 040246 | ANDA | PD-Rx Pharmaceuticals, Inc. | 55289-119 | 55289-119-02 | 2 SUPPOSITORY in 1 BOTTLE, PLASTIC (55289-119-02) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SUPPOSITORY;RECTAL | Strength | 25MG | ||||
| Approval Date: | Jun 28, 2000 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
